HDAC9 and skin cancer: Similarly, HDAC inhibition leads to increased expression of HLA class I molecules as well as MHC class I chain-related protein (MIC) A and B in Merkel cell carcinoma, another highly aggressive skin cancer [49,50], highlighting the important role of epigenetic regulators for the immune therapy of skin cancer.